Table 2.
Sociodemographic and treatment-related characteristics of the CCSs in each study arm.
| Characteristic | Study arm 1 | Study arm 2 | Study arm 3 | |
| Number of survivors, n |
|
249 | 251 | 250 |
| Median current age (years), range |
|
29 (18-58) | 30 (18-61) | 31 (18-60) |
| Median age at childhood cancer diagnosis (years), range |
|
6 (0-17) | 6 (0-17) | 6 (0-17) |
| Median time since diagnosis (years), range |
|
23 (10-46) | 23 (10-49) | 23 (10-49) |
| Gender, n (%) |
|
|
|
|
|
|
Male | 122 (49.0) | 127 (50.6) | 124 (49.6) |
|
|
Female | 127 (51.0) | 124 (49.4) | 126 (50.4) |
| Study center, n (%) |
|
|
|
|
|
|
EKZ/AMC | 114 (45.8) | 111 (44.2) | 112 (44.8) |
|
|
Erasmus MC | 80 (32.1) | 83 (33.1) | 82 (32.8) |
|
|
VUmc | 55 (22.1) | 57 (22.7) | 56 (22.4) |
| Diagnosis, n (%) |
|
|
|
|
|
|
Central nervous system tumor | 31 (12.5) | 38 (15.1) | 38 (15.2) |
|
|
Leukemia | 77 (30.9) | 66 (26.3) | 58 (23.2) |
|
|
Lymphoma | 41 (16.5) | 43 (17.2) | 48 (19.2) |
|
|
Renal tumor | 27 (10.8) | 38 (15.1) | 32 (12.8) |
|
|
Other | 73 (29.3) | 66 (26.3) | 74 (29.6) |
| Chemotherapy, n (%) |
|
199 (79.9) | 187 (74.5) | 191 (76.4) |
| Radiotherapy, n (%) |
|
95 (38.2) | 86 (34.3) | 98 (39.2) |
| Surgery, n (%) |
|
162 (65.1) | 176 (70.1) | 174 (69.6) |
| Other therapy, n (%) |
|
135 (54.2) | 129 (51.4) | 128 (51.2) |
| Recurrence of disease, n (%) |
|
39 (15.7) | 30 (12.0) | 31 (12.4) |
| Recent visit to late effect outpatient clinic (<2 years), n (%) |
|
87 (34.9) | 103 (41.0) | 98 (39.2) |